SEC Form 4 · accession 0001127602-15-001893
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah J. Schlesinger
Director
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2015 | P | 1,300 | $6.97 | A | 14,300 | I | Spouse |
| Common Stock | Jan 14, 2015 | P | 1,300 | $6.25 | A | 15,600 | I | Spouse |
| Common Stock | holding | — | — | — | 12,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were purchased pursuant to a Rule 10b5-1 trading plan.